Dr. Reddy's Laboratories has informed that the Nomination, Governance and Compensation Committee of the Board of Directors of the Company has allotted 2,253 equity shares of Rs 5 each of the Company, fully paid up, on March 1, 2021 to Employees on exercise of their Stock Options as per the following details: 1,116 equity shares of Rs 5 each pursuant to Dr. Reddy's Employees Stock Option Scheme, 2002 and 1,137 equity shares of Rs 5 each underlying 1,137 ADRs pursuant to Dr. Reddy's Employees ADR Stock Option Scheme, 2007. Further, the company has enclosed the details as required under Regulation 10(c) of SEBI (Share Based Employee Benefits) Regulation, 2014.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1867.75 |
| Dr. Reddys Labs. | 1337.95 |
| Cipla | 1457.05 |
| Zydus Lifesciences | 1108.10 |
| Lupin | 2395.10 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: